| Literature DB >> 34947015 |
Aida R Cruz-Luna1, Heriberto Cruz-Martínez2, Alfonso Vásquez-López1, Dora I Medina3.
Abstract
The use of metal nanoparticles is considered a good alternative to control phytopathogenic fungi in agriculture. To date, numerous metal nanoparticles (e.g., Ag, Cu, Se, Ni, Mg, and Fe) have been synthesized and used as potential antifungal agents. Therefore, this proposal presents a critical and detailed review of the use of these nanoparticles to control phytopathogenic fungi. Ag nanoparticles have been the most investigated nanoparticles due to their good antifungal activities, followed by Cu nanoparticles. It was also found that other metal nanoparticles have been investigated as antifungal agents, such as Se, Ni, Mg, Pd, and Fe, showing prominent results. Different synthesis methods have been used to produce these nanoparticles with different shapes and sizes, which have shown outstanding antifungal activities. This review shows the success of the use of metal nanoparticles to control phytopathogenic fungi in agriculture.Entities:
Keywords: agriculture; antifungal activities; crop protection; fungi; metallic nanoparticles
Year: 2021 PMID: 34947015 PMCID: PMC8706727 DOI: 10.3390/jof7121033
Source DB: PubMed Journal: J Fungi (Basel) ISSN: 2309-608X
Figure 1This is an illustration of the possible mechanisms of action of metal nanoparticles on phytopathogenic fungi. These are as follows: (a) ions are released by nanoparticles and bind to certain protein groups, which affect the function of essential membrane proteins and interfere with cell permeability. (b) The nanoparticles inhibit the germination of the conidia and suppress their development. (c) Nanoparticles and released ions disrupt electron transport, protein oxidation, and alter membrane potential. (d) They also interfere with protein oxidative electron transport. (e) They affect the potential of the mitochondrial membrane by increasing the levels of transcription of genes in response to oxidative stress (ROS). (f) ROS induces the generation of reactive oxygen species, triggering oxidation reactions catalyzed by the different metallic nanoparticles, causing severe damage to proteins, membranes, and deoxyribonucleic acid (DNA), and interfering with nutrient absorption. (g) The ions of the nanoparticles have a genotoxic effect that destroys DNA, therefore causing cell death [58,59,60,61,62].
Figure 2A generalized representation of the green synthesis of metallic nanoparticles [75].
Characteristics and antifungal evaluations of Ag nanoparticles.
| Nanoparticle Properties | Antifungal Properties | Ref. | |||
|---|---|---|---|---|---|
| Synthesis Method | Size (nm) | Shape | Specie of Fungi | Evaluation Method | |
| Biological synthesis | 17 and 25.7 | Spherical | In vitro | [ | |
| Biological synthesis | 23 | Spherical |
| In vitro and in vivo | [ |
| Biological synthesis | 10–50 | Spherical | In vitro | [ | |
| Biological synthesis | 50 | Spherical | In vitro | [ | |
| Biological synthesis | - | - |
| In vitro | [ |
| Biological synthesis | 20 | Spherical |
| In vitro | [ |
| Biological synthesis | 29 | Spherical |
| In vitro | [ |
| Biological synthesis | 10–21 | Spherical |
| In vitro and in vivo | [ |
| Biological synthesis | 12–16 | Spherical | In vitro | [ | |
| Biological synthesis | - | - | In vitro | [ | |
| Biological synthesis | 75.3 | Spherical | In vitro | [ | |
| Biological synthesis | - | - | In vitro | [ | |
| Biological synthesis | - | - | In vitro and in vivo | [ | |
| Biological synthesis | 50.6 | Spherical | In vitro | [ | |
| Biological synthesis | 10–20 | Spherical | In vitro | [ | |
| Biological synthesis | 10–50 | Spherical and oval | In vitro | [ | |
| Biological synthesis | 68 | - |
| In vitro and in vivo | [ |
| Biological synthesis | 15–30 | Spherical |
| In vitro and in vivo | [ |
| Biological synthesis | 10–32 | Spherical | In vitro | [ | |
| Biological synthesis | 35–55 | Spherical | In vitro | [ | |
| Biological synthesis | 20–25 | Spherical | In vitro | [ | |
| Biological synthesis | 3.7–29.3 | Spherical |
| In vitro | [ |
| Biological synthesis | 4–53 | Various morphologies | In vitro | [ | |
| Biological synthesis | 11 and 14 | Spherical |
| In vivo and in vitro | [ |
| Biological synthesis | 10 | Spherical | In vitro | [ | |
| Biological synthesis | 5–30 | Spherical |
| In vitro | [ |
| Biological synthesis | 10–30 | Spherical |
| In vitro and in vivo | [ |
| Biological synthesis | 12.7 | Spherical |
| In vitro | [ |
| Biological synthesis | 5–30 | Spherical | In vitro | [ | |
| Biological synthesis | 16–20 | Spherical | In vitro | [ | |
| Biological synthesis | 25–43 | Spherical | In vitro | [ | |
| Biological synthesis |
| In vitro | [ | ||
| Biological synthesis | 3–10 | Spherical | In vitro | [ | |
| Biological synthesis | 22.33–41.95 | Spherical |
| In vitro | [ |
| Biological synthesis | 15–400 | Spherical | In vitro | [ | |
| Biological synthesis | 20–40 | Spherical | In vitro | [ | |
| Biological synthesis | 10–12 | Spherical | In vitro | [ | |
| Biological synthesis | 3–13 | Spherical | In vitro | [ | |
| Biological synthesis | 1–20 | Spherical |
| In vitro | [ |
| Biological synthesis | 5–30 | Spherical | In vitro | [ | |
| Biological synthesis | 19.8–44.9 | Spherical |
| In vitro | [ |
| Biological synthesis | 5–10 | Spherical | In vitro | [ | |
| Biological synthesis | 69.24 | - | In vitro | [ | |
| Biological synthesis | 19.5–20.9 | Spherical |
| In vitro | [ |
| Biological synthesis (Sodium alginate) | 6 and 40 | Spherical |
| In vitro | [ |
| Biological synthesis | 93 ± 11 | Spherical | In vitro | [ | |
| Biological synthesis (Glucose) | 5–24 | Spherical |
| In vitro | [ |
| Chemical synthesis | 40–60 | Spherical |
| In vitro | [ |
| Chemical synthesis | 21 ± 2 | Spherical |
| In vitro | [ |
| Chemical synthesis | 52 | Spherical | In vitro | [ | |
| Chemical synthesis | 30 | Spherical | In vitro | [ | |
| Chemical synthesis | 19–24 | Spherical |
| In vitro | [ |
| Chemical synthesis | 25–32 | - | In vitro | [ | |
| Chemical synthesis | 20 | Spherical |
| In vitro | [ |
| Chemical synthesis | 100 | Spherical | In vitro | [ | |
| Chemical synthesis | - | - |
| In vitro | [ |
| Chemical synthesis | 47 | Spherical |
| In vitro | [ |
| Commercial | 7–25 | - | In vitro | [ | |
| Commercial | 20–30 | - | In vitro and in vivo | [ | |
| Commercial | - | - | In vitro and in vivo | [ | |
| Commercial | 20 | - |
| In vitro | [ |
| Commercial | <100 | - | In vitro and in vivo | [ | |
| Commercial | - | - | In vitro | [ | |
| Commercial | 40–50 | Spherical |
| In vitro | [ |
| Commercial | 20–30 | - |
| In vitro and in vivo | [ |
| Commercial | <100 | - |
| In vitro and in vivo | [ |
| Commercial | 4–8 | - |
| In vitro and in vivo | [ |
| Commercial | 38 | Spherical | In vitro | [ | |
| Commercial | 7–25 | - |
| In vitro | [ |
| Commercial | - | - |
| In vitro and in vivo | [ |
| Commercial | 5–10 | - |
| In vitro and in vivo | [ |
| Physical synthesis | 5–65 | Spherical |
| In vitro | [ |
| Physical synthesis | 15–100 | Spherical |
| In vitro | [ |
| Physical synthesis | 5–15 | Spherical |
| In vitro and in vivo | [ |
Figure 3Microscopic images of SEM and TEM of F. graminearum in the absence (A) and presence (B) of the synthesized silver nanoparticle [116].
Characteristics and antifungal evaluations of Cu nanoparticles.
| Nanoparticle Properties | Antifungal Properties | Ref. | |||
|---|---|---|---|---|---|
| Synthesis Method | Size (nm) | Shape | Specie of Fungi | Evaluation Method | |
| Biological synthesis | 42–90 | Spherical | In vitro | [ | |
| Biological synthesis | - | Spherical | In vitro | [ | |
| Biological synthesis | 26–40 | Spherical | In vitro | [ | |
| Biological synthesis | 68 | - |
| In vitro | [ |
| Biological synthesis | 200–500 | Faceted | In vitro | [ | |
| Biological synthesis | 200–500 | Faceted | In vitro and in vivo | [ | |
| Biological synthesis | 5 | Spherical |
| In vitro | [ |
| Biological synthesis | 10 | Spherical | In vitro | [ | |
| Biological synthesis | 3.6–59 | Spherical | In vitro | [ | |
| Biological synthesis | 53–174 | Spherical | In vitro | [ | |
| Chemical synthesis | 20–50 | Spherical | In vitro | [ | |
| Chemical synthesis | - | - |
| In vitro | [ |
| Chemical synthesis | 14 ± 2 | Spherical | In vitro | [ | |
| Chemical synthesis | 30–300 | Spherical | In vitro | [ | |
| Chemical synthesis | 3–30 | Spherical | In vitro | [ | |
| Chemical synthesis | 25–35 | Spherical |
| In vitro and in vivo | [ |
| Chemical synthesis | 14–37 | Truncated octahedrons |
| In vitro | [ |
| Commercial | 25 | - | In vitro and in vivo | [ | |
| Commercial | - | - | In vitro | [ | |
| Commercial | 20–30 | - |
| In vitro and in vivo | [ |
| Commercial | 20 | Spherical | In vitro | [ | |
| Commercial | 25 | - |
| In vitro and in vivo | [ |
Figure 4Cu nanoparticles synthesized with different shapes and sizes: (a) spherical shapes [158] and (b) faceted shapes [152].